113
Views
8
CrossRef citations to date
0
Altmetric
Letters to the Editor

Pilot study of rituximab plus donor-lymphocyte infusion to prevent or treat relapse in B-cell lymphoma after allogeneic stem cell transplantation

, , , , , & show all
Pages 146-148 | Received 30 May 2009, Accepted 19 Aug 2009, Published online: 30 Sep 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Javier El-Bietar & Catherine Bollard. (2011) T-Cell Therapies for Epstein-Barr Virus–Associated Lymphomas. Pediatric Hematology and Oncology 28:8, pages 627-639.
Read now
A John Barrett & Minoo Battiwalla. (2010) Relapse after allogeneic stem cell transplantation. Expert Review of Hematology 3:4, pages 429-441.
Read now
Arnon Nagler & Avichai Shimoni. (2010) Immunotherapy for B-cell lymphoma. Leukemia & Lymphoma 51:1, pages 7-9.
Read now

Articles from other publishers (5)

Miriam Marangon, Carlo Visco, Anna Maria Barbui, Annalisa Chiappella, Alberto Fabbri, Simone Ferrero, Sara Galimberti, Stefano Luminari, Gerardo Musuraca, Alessandro Re, Vittorio Ruggero Zilioli & Marco Ladetto. (2021) Allogeneic Stem Cell Transplantation in Mantle Cell Lymphoma in the Era of New Drugs and CAR-T Cell Therapy. Cancers 13:2, pages 291.
Crossref
Rocío Parody & Anna Sureda. 2017. Haploidentical Stem Cell Transplantation. Haploidentical Stem Cell Transplantation 119 140 .
David L. Porter. (2011) Allogeneic Immunotherapy to Optimize the Graft-versus-Tumor Effect: Concepts and Controversies. Hematology 2011:1, pages 292-298.
Crossref
Alison Rager & David L. Porter. (2011) Cellular therapy following allogeneic stem-cell transplantation. Therapeutic Advances in Hematology 2:6, pages 409-428.
Crossref
Koen van Besien. (2011) Current status of allogeneic transplantation for aggressive non-Hodgkin lymphoma. Current Opinion in Oncology 23:6, pages 681-691.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.